Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain?

Brewer JA, Bowen S, Smith JT, Marlatt GA, Potenza MN.

Addiction. 2010 Oct;105(10):1698-706. doi: 10.1111/j.1360-0443.2009.02890.x.

3.

The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders.

Dakwar E, Levin FR.

Harv Rev Psychiatry. 2009;17(4):254-67. doi: 10.1080/10673220903149135. Review.

4.

[Mindfulness based interventions for addictive disorders: a review].

Skanavi S, Laqueille X, Aubin HJ.

Encephale. 2011 Oct;37(5):379-87. doi: 10.1016/j.encep.2010.08.010. Epub 2011 Feb 8. Review. French.

PMID:
22032281
5.

Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.

Brady KT, Sinha R.

Am J Psychiatry. 2005 Aug;162(8):1483-93. Review.

PMID:
16055769
6.

A systematic review of neurobiological and clinical features of mindfulness meditations.

Chiesa A, Serretti A.

Psychol Med. 2010 Aug;40(8):1239-52. doi: 10.1017/S0033291709991747. Epub 2009 Nov 27. Review.

PMID:
19941676
7.

Current status of co-occurring mood and substance use disorders: a new therapeutic target.

Pettinati HM, O'Brien CP, Dundon WD.

Am J Psychiatry. 2013 Jan;170(1):23-30. doi: 10.1176/appi.ajp.2012.12010112. Review.

8.
9.

Mindfulness and bodily distress.

Fjorback LO.

Dan Med J. 2012 Nov;59(11):B4547. Review.

PMID:
23171754
10.

Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.

Witkiewitz K, Lustyk MK, Bowen S.

Psychol Addict Behav. 2013 Jun;27(2):351-65. doi: 10.1037/a0029258. Epub 2012 Jul 9. Review.

11.

Abnormal reward functioning across substance use disorders and major depressive disorder: Considering reward as a transdiagnostic mechanism.

Baskin-Sommers AR, Foti D.

Int J Psychophysiol. 2015 Nov;98(2 Pt 2):227-39. doi: 10.1016/j.ijpsycho.2015.01.011. Epub 2015 Feb 3. Review.

PMID:
25655926
12.

[The history of Mindfulness put to the test of current scientific data: unresolved questions].

Trousselard M, Steiler D, Claverie D, Canini F.

Encephale. 2014 Dec;40(6):474-80. doi: 10.1016/j.encep.2014.08.006. Epub 2014 Sep 5. Review. French.

PMID:
25194754
13.

Critical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic review.

Jain FA, Walsh RN, Eisendrath SJ, Christensen S, Rael Cahn B.

Psychosomatics. 2015 Mar-Apr;56(2):140-52. doi: 10.1016/j.psym.2014.10.007. Epub 2014 Oct 22. Review.

14.

Effects of mindfulness on psychological health: a review of empirical studies.

Keng SL, Smoski MJ, Robins CJ.

Clin Psychol Rev. 2011 Aug;31(6):1041-56. doi: 10.1016/j.cpr.2011.04.006. Epub 2011 May 13. Review.

15.

Mindfulness-based cognitive therapy: theory and practice.

Sipe WE, Eisendrath SJ.

Can J Psychiatry. 2012 Feb;57(2):63-9. Review.

PMID:
22340145
16.

Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change.

Witkiewitz K, Bowen S, Harrop EN, Douglas H, Enkema M, Sedgwick C.

Subst Use Misuse. 2014 Apr;49(5):513-24. doi: 10.3109/10826084.2014.891845. Review.

PMID:
24611847
17.

The neuroscience of mindfulness meditation.

Tang YY, Hölzel BK, Posner MI.

Nat Rev Neurosci. 2015 Apr;16(4):213-25. doi: 10.1038/nrn3916. Epub 2015 Mar 18. Review.

PMID:
25783612
18.

Treatments for co-occurring depression and substance use in young people: a systematic review.

Deady M, Teesson M, Kay-Lambkin FJ.

Curr Drug Abuse Rev. 2014;7(1):3-17. Review.

PMID:
25323123
19.

The role of mindfulness in positive reappraisal.

Garland E, Gaylord S, Park J.

Explore (NY). 2009 Jan-Feb;5(1):37-44. doi: 10.1016/j.explore.2008.10.001. Review.

20.

Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Roth RM, Brunette MF, Green AI.

Curr Psychiatry Rep. 2005 Aug;7(4):283-91. Review.

PMID:
16098282

Supplemental Content

Support Center